The Crucial Role of Monitoring in Cold Chain Pharma: Ensuring Safety and Effectiveness

The cold chain logistics market in Asia Pacific is expected to reach $133.97 billion by 2027. It is a tremendous and complicated process that is very much life-saving. The demand for medicine and PPE is driven by an increase in lifestyle-related and chronic illness and diseases as well as the growing request for over-the-counter medication such as minerals, vitamins, pain-killers, and more.

Time, place, condition, these are the 3 main considerations everyone knows to consider when planning cold chain logistics. But, what else?

In this exclusive interview, we invited Ana Martinez Lozano, Assistant Director Distribution & Logistics Quality EMEA Lead at MSD, Marco Gaudesi, Head of GSDP & Cold Chain at MSF (Doctors without Borders), and Henri Lee, Group Managing Director at Aeris Dynamics to give us insights on the latest technology to better improve a temperature sensitive and controlled shipment, tips on how common challenges in this area can be mitigated, and other precautions that needs to be considered when transporting medicine such as counterfeit goods and security.